Risk Profile Improvements
- Material Weakness (improved) — Material weaknesses remain unremediated but remediation has advanced with implemented controls now in testing phase.
Anteris raises $320M, launches U.S. PARADIGM Trial, exits going-concern status
Filed May 12, 2026 · Period ending March 31, 2026 · Compared to 10-Q May 13, 2025 · ~2 min read
5 material changes detected in this filing.
Create a free account to read the full summary — it takes 30 seconds.
Partner
Trade AVR commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Generated by AI · Jun 1, 2026 6:23 PM